Mark Andrew White is of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 69,140 shares of RCKT, which is worth approximately $1.17 Million. The most recent transaction as insider was on Oct 31, 2024, when has been sold 3,080 shares (Common Stock) at a price of $16.62 per share, resulting in proceeds of $51,189. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.1K
4.26% 3M change
9.81% 12M change
Total Value Held $1.17 Million

Mark Andrew White Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 31 2024
SELL
Open market or private sale
$51,189 $16.62 p/Share
3,080 Reduced 4.26%
69,140 Common Stock
Jul 08 2024
SELL
Open market or private sale
$61,700 $20.39 p/Share
3,026 Reduced 4.02%
72,220 Common Stock
Apr 08 2024
SELL
Open market or private sale
$308,788 $24.64 p/Share
12,532 Reduced 14.28%
75,226 Common Stock
Feb 16 2024
BUY
Grant, award, or other acquisition
-
11,096 Added 11.22%
87,758 Common Stock
Apr 04 2023
BUY
Grant, award, or other acquisition
-
76,662 Added 50.0%
76,662 Common Stock, par valu...
MAW

Mark Andrew White

Cranbury, NJ

Track Institutional and Insider Activities on RCKT

Follow ROCKET PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Track Activities on RCKT